𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry

✍ Scribed by Kandatege Wimalasena


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
525 KB
Volume
31
Category
Article
ISSN
0198-6325

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Vesicular monoamine transporters (VMAT) are responsible for the uptake of cytosolic monoamines into synaptic vesicles in monoaminergic neurons. Two closely related VMATs with distinct pharmacological properties and tissue distributions have been characterized. VMAT1 is preferentially expressed in neuroendocrine cells and VMAT2 is primarily expressed in the CNS. The neurotoxicity and addictive properties of various psychostimulants have been attributed, at least partly, to their interference with VMAT2 functions. The quantitative assessment of the VMAT2 density by PET scanning has been clinically useful for early diagnosis and monitoring of the progression of Parkinson's and Alzheimer's diseases and drug addiction. The classical VMAT2 inhibitor, tetrabenazine, has long been used for the treatment of chorea associated with Huntington's disease in the United Kingdom, Canada, and Australia, and recently approved in the United States. The VMAT2 imaging may also be useful for exploiting the onset of diabetes mellitus, as VMAT2 is also expressed in the β‐cells of the pancreas. VMAT1 gene SLC18A1 is a locus with strong evidence of linkage with schizophrenia and, thus, the polymorphic forms of the VMAT1 gene may confer susceptibility to schizophrenia. This review summarizes the current understanding of the structure–function relationships of VMAT2, and the role of VMAT2 on addiction and psychostimulant‐induced neurotoxicity, and the therapeutic and diagnostic applications of specific VMAT2 ligands. The evidence for the linkage of VMAT1 gene with schizophrenia and bipolar disorder I is also discussed. © 2010 Wiley Periodicals, Inc. Med Res Rev 31: 483‐519, 2011


📜 SIMILAR VOLUMES


Medicinal chemistry and molecular pharma
✍ Graham A.R. Johnston; Mary Chebib; Rujee K. Duke; Kenneth N. Mewett; Ann D. Mitr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

GABA and glutamate are the major inhibitory and excitatory neurotransmitters, respectively, in the human brain. Many GABA and glutamate receptors and transporters are key protein targets for drug development, and many known CNS drugs act on these targets. There have been a substantial number of trad